EC Number |
Inhibitors |
Structure |
---|
3.2.1.10 | (-)-1-azafagomine |
i.e.(3R,4R,5R)-4,5-dihydroxy-3-hydroxymethylhexahydropyridazine, competitive, slow inhibition process, difference in Ki values depend almost entirely on changes in the binding rate constant, direct binding model, some analogues of the compound are also inhibitory with less efficiency |
|
3.2.1.10 | (2R,3S,4S)-1-[(2S,3S)-2,4-dihydroxy-3-(tridecyloxy)butyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium |
- |
|
3.2.1.10 | (2R,3S,4S)-1-[(2S,3S)-2,4-dihydroxy-3-methoxybutyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium |
- |
|
3.2.1.10 | (2R,3S,4S)-1-[(2S,3S)-3-(benzyloxy)-2,4-dihydroxybutyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium |
- |
|
3.2.1.10 | (2R,3S,4S)-1-[(2S,3S)-3-ethoxy-2,4-dihydroxybutyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium |
- |
|
3.2.1.10 | (2S,3S,4S,5S)-2-(hydroxymethyl)-5-[3-(4-methylphenyl)propyl]pyrrolidine-3,4-diol |
- |
|
3.2.1.10 | (2S,3S,4S,5S)-2-(hydroxymethyl)-5-[4-(4-methoxyphenyl)butyl]pyrrolidine-3,4-diol |
- |
|
3.2.1.10 | (2S,3S,4S,5S)-2-[4-(3,5-difluorophenyl)butyl]-5-(hydroxymethyl)pyrrolidine-3,4-diol |
good inhibition activities against intestinal isomaltase and sucrase |
|
3.2.1.10 | 1,2,3-tri-O-galloyl-beta-D-glucose |
about 20% inhibition at 1 mM |
|
3.2.1.10 | 1,4-anhydro-4-thio-D-arabinitol |
- |
|